At LBIC, just up the road from the Crick Institute and Google, Synthace’s multidisciplinary team of wet-lab biologists, data scientists and software engineers are working together to develop Antha, a cloud-based software platform and operating system that enables the design, planning and automated execution of experimental biology protocols and processes using labs’ existing equipment.
In September 2017, the company announced the successful raise of a further £7.3m in venture capital funding. Synthace will use this latest investment to expand their software and wet-lab teams, aiming to grow from around 25 to over 40 employees in the next 12 months. This investment in the team will expand sales and marketing and support the ongoing development of the Antha platform, including writing Antha drivers for a growing range of lab instrumentation and equipment from multiple manufacturers.
Rolling out Antha Antha is already in use by clients such as MSD, GSK, Dow Agrosciences and new entrants into the biology arena including Microsoft. At the recent BioProcess International conference in Boston, USA, Synthace and MSD presented the first results of Antha rollout for the rapid and robust construction of a wide range of vectors for bioprocess optimisation. Throughput was increased by an order of magnitude and enabled an estimated 25% reduction in vector construction timelines, a 33% reduction in costs, and dramatically reduced manual steps. This enabled the rapid investigation of large arrays of genetic options alongside process factors for full bioprocess optimisation.
Over the summer, Synthace also announced partnerships including with product design and development firm Cambridge Consultants, and an Innovate UK-supported collaboration with Oxford BioMedica, the Cell and Gene Therapy Catapult and Stratophase exploring a next generation manufacturing platform for gene and cell therapies. Biology is not an engineering discipline – yet! Synthace has set its sights on bringing engineering approaches, automation and machine learning to biology, empowering researchers to accelerate biotechnology and enable faster breakthroughs. To find out more, visit synthace.com and follow @synthace. For more information about careers at Synthace, visit: synthace.com/join-us